(Q50247277)

28 February 2018

title

High-intensity focused ultrasound in the management of prostate cancer. (English)

1 reference

28 February 2018

0 references

Christian Chaussy

1

1 reference

28 February 2018

Stefan Thüroff

series ordinal

2

1 reference

28 February 2018

publication date

1 March 2010

1 reference

28 February 2018

Expert Review of Medical Devices

published in

1 reference

28 February 2018

volume

7

1 reference

28 February 2018

issue

2

1 reference

28 February 2018

page(s)

209-217

1 reference

28 February 2018

Extracorporeally induced destruction of kidney stones by shock waves.

cites work

1 reference

Technology insight: High-intensity focused ultrasound for urologic cancers

21 January 2018

1 reference

Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography.

21 January 2018

1 reference

Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.

21 January 2018

1 reference

Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer.

21 January 2018

1 reference

Results and side effects of high-intensity focused ultrasound in localized prostate cancer.

21 January 2018

1 reference

Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome.

21 January 2018

1 reference

High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric Study

21 January 2018

1 reference

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience

21 January 2018

1 reference

Control of prostate cancer by transrectal HIFU in 227 patients.

21 January 2018

1 reference

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

21 January 2018

1 reference

Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer

21 January 2018

1 reference

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

21 January 2018

1 reference

The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection.

21 January 2018

1 reference

Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study

21 January 2018

1 reference

Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.

21 January 2018

1 reference

Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

21 January 2018

1 reference

To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?

21 January 2018

1 reference

Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging

21 January 2018

1 reference

How good is MRI at detecting and characterising cancer within the prostate?

21 January 2018

1 reference

Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.

21 January 2018

1 reference

MRI appearance of prostate following transrectal HIFU ablation of localized cancer.

21 January 2018

1 reference

MR imaging of prostate after treatment with high-intensity focused ultrasound

21 January 2018

1 reference

Assessment of thermal tissue ablation with MR elastography.

21 January 2018

1 reference

Real-time visualization of high-intensity focused ultrasound treatment using ultrasound imaging.

21 January 2018

1 reference

The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.

21 January 2018

1 reference

Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer

21 January 2018

1 reference

Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.

21 January 2018

1 reference

Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation.

21 January 2018

1 reference

Investigation of HIFU-induced anti-tumor immunity in a murine tumor model

21 January 2018

1 reference

Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.

21 January 2018

1 reference

High-intensity focused ultrasound therapy for clinically localized prostate cancer

21 January 2018

1 reference

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERD.09.66

1 reference

28 February 2018

PubMed ID

20214427

1 reference

28 February 2018